Laura Vallejo‐Torres

Estimating a cost‐effectiveness threshold for the Spanish NHS

Laura Vallejo‐Torres, Borja García‐Lorenzo, Pedro Serrano‐Aguilar · Health Economics · 2017 · 302 citations

Social Sciences, Economics, Pharmacoeconomics +17

Measuring current and future cost of skin cancer in England

Laura Vallejo‐Torres, Stephen Morris, Jonas Minet Kinge et al. · Journal of Public Health · 2013 · 103 citations

Medicine, Health Policy, Oncology +17

Integrating health economics modeling in the product development cycle of medical devices: A Bayesian approach

Laura Vallejo‐Torres, Lotte Steuten, Martin Buxton et al. · International Journal of Technology Assessment in Health Care · 2008 · 93 citations · Full text

Management, Business Economics, Pharmacoeconomics +17

Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study

Laura Vallejo‐Torres, Miquel Pujol, Evelyn Shaw et al. · BMJ Open · 2018 · 73 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +17

Risk Factors for Treatment Failure and Mortality Among Hospitalized Patients With Complicated Urinary Tract Infection: A Multicenter Retrospective Cohort Study (RESCUING Study Group)

Noa Eliakim‐Raz, Tanya Babitch, Evelyn Shaw et al. · Clinical Infectious Diseases · 2018 · 73 citations · Full text

Veterinary Medicine, Infectious Diseases, Antimicrobial Pharmacotherapy +10